Scrip
Cephalon and Barr settle US Fentora patent dispute
19 November 2009
Nancy Faigen
Cephalon has entered into an agreement-in-principle whereby it will give Barr Pharmaceuticals (now part of
Teva Pharmaceuticals Industries) a licence to sell a generic version of the pain therapy, Fentora (fentanyl buccal tablets), in 2018 as part of a patent lawsuit settlement, according to a recent...
Please Login to read the full article.
19 November 2009
Nancy Faigen
Please Login to read the full article.
RELATED CONTENT
NEWS
- Teva launches Yaz generic in the US, triggering patent infringement suit by Bayer
- Mylan obtains licence in settlement of venlafaxine XR patent dispute
- US court rules for Teva, claiming Merck & Co's Temodar patent is unenforceable
- Dr Reddy's joins others filing ANDAs for generic Lipitor
COMMENT
Other Informa Comment
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
